相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
Janne Nestvold et al.
ONCOIMMUNOLOGY (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death
Leonard Jagot-Lacoussiere et al.
CANCER RESEARCH (2016)
The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
T. Yamazaki et al.
CELL DEATH AND DIFFERENTIATION (2016)
Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
Bengt Erik Haug et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The oncolytic peptide LTX-315 triggers immunogenic cell death
H. Zhou et al.
CELL DEATH & DISEASE (2016)
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Tania Love Aaes et al.
CELL REPORTS (2016)
The oncolytic peptide LTX-315 triggers necrotic cell death
Sabrina Forveille et al.
CELL CYCLE (2015)
DNA damage-induced nuclear translocation of Apaf-1 is mediated by nucleoporin Nup107
Leonard Jagot-Lacoussiere et al.
CELL CYCLE (2015)
Live to die another way: modes of programmed cell death and the signals emanating from dying cells
Yaron Fuchs et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
Heng Zhou et al.
ONCOTARGET (2015)
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Carolien A. Koks et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315
Ketil Andre Camilio et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
T. Yamazaki et al.
CELL DEATH AND DIFFERENTIATION (2014)
High hydrostatic pressure induces immunogenic cell death in human tumor cells
Jitka Fucikova et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
Abdul Qader Sukkurwala et al.
ONCOIMMUNOLOGY (2014)
LTX-315 (Oncopore™) A short synthetic anticancer peptide and novel immunotherapeutic agent
Ketil Andre Camilio et al.
ONCOIMMUNOLOGY (2014)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp et al.
ONCOIMMUNOLOGY (2014)
Trial Watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic γδ T Lymphocytes to Tumor Beds
Telma Lanca et al.
JOURNAL OF IMMUNOLOGY (2013)
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
Abhishek D. Garg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines
Weiyi Peng et al.
CANCER RESEARCH (2012)
Recent Advances in Computational Modeling of α-Helical Membrane-Active Peptides
Anton A. Polyansky et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Laurie Menger et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
Michelle Hong et al.
CANCER RESEARCH (2011)
Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
Alicia Gonzalez-Martin et al.
CANCER RESEARCH (2011)
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I. Martins et al.
ONCOGENE (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Desirable cell death during anticancer chemotherapy
Clara Locher et al.
CLEARANCE OF DYING CELLS IN HEALTHY AND DISEASED IMMUNE SYSTEMS (2010)
Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1α
Noriho Iida et al.
CANCER RESEARCH (2010)
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Laurence Zitvogel et al.
CLINICAL CANCER RESEARCH (2010)
Targeting AAC-11 in cancer therapy
Audrey Faye et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes
Ehsan Sarafraz-Yazdi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation
Patricia Rigou et al.
EMBO JOURNAL (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
Paul Hatfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients
V. Piddubnyak et al.
CELL DEATH AND DIFFERENTIATION (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Feed forward cycle of hypotonic stress-induced ATP release, purinergic receptor activation, and growth stimulation of prostate cancer cells
R Nandigama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides
Hiromi Sato et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
SJ Gardai et al.
CELL (2005)
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy
M Gough et al.
JOURNAL OF IMMUNOLOGY (2005)
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site
TN Do et al.
ONCOGENE (2003)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells
M Kanovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
